Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EZETIMIBE\ROSUVASTATIN for Dyslipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 55 adverse event reports in the FDA FAERS database where EZETIMIBE\ROSUVASTATIN was used for Dyslipidaemia.

Most Reported Side Effects for EZETIMIBE\ROSUVASTATIN

Side Effect Reports % Deaths Hosp.
Myalgia 58 17.6% 0 9
Acute kidney injury 24 7.3% 0 12
Arthralgia 17 5.2% 0 0
Blood creatine phosphokinase increased 17 5.2% 1 11
Leriche syndrome 16 4.9% 0 16
Muscle spasms 16 4.9% 0 0
Peripheral arterial occlusive disease 16 4.9% 0 16
Asthenia 14 4.3% 0 7
Drug abuse 14 4.3% 0 8
Hepatic cytolysis 12 3.7% 1 6
Metabolic acidosis 12 3.7% 0 6
Drug reaction with eosinophilia and systemic symptoms 11 3.3% 3 11
Dyspnoea 11 3.3% 0 4
Hyperkalaemia 11 3.3% 0 2
Ischaemic nephropathy 11 3.3% 0 11

Other Indications for EZETIMIBE\ROSUVASTATIN

Product used for unknown indication (134) Hypercholesterolaemia (41) Coronary artery disease (12) Hyperlipidaemia (11) Ischaemic heart disease prophylaxis (7) Blood cholesterol increased (6) Type iia hyperlipidaemia (6) Myocardial ischaemia (5)

Other Drugs Used for Dyslipidaemia

ATORVASTATIN (4,796) ROSUVASTATIN (2,032) SIMVASTATIN (1,253) EVOLOCUMAB (1,056) EZETIMIBE (787) PRAVASTATIN (747) FENOFIBRATE (606) EZETIMIBE\SIMVASTATIN (302) ATORVASTATIN\EZETIMIBE (239) DEVICE (172)

Related Pages

EZETIMIBE\ROSUVASTATIN Full Profile All Dyslipidaemia Drugs EZETIMIBE\ROSUVASTATIN Demographics EZETIMIBE\ROSUVASTATIN Timeline